Both GLP-1 and PYY have been found to inhibit appetite (Stubbs et al., 2018), reduce body weight, and improve insulin resistance in obese mice (McNabney and Henagan, 2017; Blanco, 2020). Here, PYY is linked to Insulin resistance.